| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 15.636 | 39.963 | 43.699 | 61.502 | 85.723 | 82.834 |
| Total Income - EUR | - | - | - | - | 15.636 | 40.022 | 43.743 | 61.871 | 85.867 | 82.843 |
| Total Expenses - EUR | - | - | - | - | 1.388 | 2.532 | 4.289 | 12.932 | 10.987 | 22.652 |
| Gross Profit/Loss - EUR | - | - | - | - | 14.249 | 37.490 | 39.454 | 48.939 | 74.879 | 60.191 |
| Net Profit/Loss - EUR | - | - | - | - | 13.779 | 36.363 | 38.517 | 48.322 | 74.022 | 58.899 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Blupoint Bioresearch S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 91 | 47 | 4 | 600 | 2.520 | 33.192 |
| Current Assets | - | - | - | - | 14.157 | 36.844 | 42.199 | 69.446 | 86.263 | 52.450 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 24 | 0 |
| Receivables | - | - | - | - | 1.125 | 17.669 | 20.535 | 36.601 | 45.052 | 42.892 |
| Cash | - | - | - | - | 13.032 | 19.175 | 21.664 | 32.845 | 41.186 | 9.558 |
| Shareholders Funds | - | - | - | - | 13.822 | 36.413 | 38.566 | 48.371 | 74.071 | 58.948 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 426 | 478 | 3.637 | 21.675 | 14.712 | 26.695 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Blupoint Bioresearch S.r.l.